Which indicators should be analyzed to assess the gene therapy market?
A gene therapy report analyzes clinical pipelines, viral and non-viral vector platforms, regulatory approvals, targeted indications, bioproduction capacity, development costs, pharmaceutical partnerships, funding and reimbursement challenges. These indicators help biotech companies, pharmaceutical firms, investors, CDMOs and healthcare decision-makers assess the commercial potential of programs, scientific risks and growth opportunities.